TIDMBPCR

RNS Number : 4139N

BioPharma Credit PLC

22 September 2023

 
BIOPHARMA CREDIT PLC (the 'Company') 
 
 As at the 31 August 2023 the unaudited net asset value per Ordinary Share, including current 
 period revenue, was 102.39 cents. The Company's factsheet will be located on the Company's 
 website, http://bpcruk.com. 
 
 Dated: 22 September 2023 
 
 Legal Entity Identifier 213800AV55PYXAS7SY24

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NAVLTMITMTBTBIJ

(END) Dow Jones Newswires

September 22, 2023 11:00 ET (15:00 GMT)

Biopharma Credit (LSE:BPCP)
Historical Stock Chart
From Jan 2025 to Feb 2025 Click Here for more Biopharma Credit Charts.
Biopharma Credit (LSE:BPCP)
Historical Stock Chart
From Feb 2024 to Feb 2025 Click Here for more Biopharma Credit Charts.